The past three administrations have tried to limit gain-of-function research. The second Trump administration might be the first one to be successful at doing so.

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. Lifesaving HIV treatments. Cures for hepatitis C. New tuberculosis regimens and a vaccine for RSV.

President Donald Trump has ended the federal security detail for Dr. Anthony Fauci, the infectious disease expert who advised him on the COVID-19 pandemic.

I believe in the rule of law,” President Biden announced Monday morning, but “these are exceptional circumstances, and I cannot in good conscience do nothing” — and so he detonated the rule of law on his last morning in the White House by pardoning every Biden kinfolk with sticky fingers for foreign windfalls,

President Joe Biden granted pardons to several prominent public servants Monday who have faced attacks from President-elect Donald Trump in one of his final acts in office.

President Donald Trump had his first official interview in the Oval Office Wednesday and reflected on his return to the

For decades, researchers with funding from the NIH’s National Institute of Allergy and Infectious Diseases have labored ... Straight, white men are still overrepresented in clinical research ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

Trump said he would not feel responsible if anything happened to Fauci as a result of his federal security clearances being cut.

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the Covid pandemic, as acting head of the NIH.

The president removed the security detail that has protected the former head of the National Institute of Allergy and Infectious Diseases.

Fauci served as the leading US infectious disease expert during the COVID-19 pandemic, was under security provided by the NIH.